Treatment of Asthma with Controlled Inhalers

Stepwise Approach to Asthma Management

The American College of Chest Physicians recommends a stepwise approach to asthma management, with inhaled corticosteroids (ICS) as the cornerstone therapy for persistent asthma and the addition of long-acting beta-agonists (LABA) for patients not adequately controlled on ICS alone 1, 2
For mild intermittent asthma, the preferred treatment is as-needed short-acting beta-agonist (SABA), and each step includes patient education, environmental control, and management of comorbidities 3, 4
For mild persistent asthma, the preferred treatment is low-dose inhaled corticosteroid (ICS) daily, with alternative treatments including leukotriene receptor antagonists, cromolyn, nedocromil, or theophylline 3, 1, 4, 2
The American Academy of Allergy, Asthma, and Immunology recommends that leukotriene modifiers have advantages of ease of use and high compliance rates 3

The American Thoracic Society recommends assessing asthma control regularly and adjusting therapy accordingly 1
The Mayo Clinic recommends stepping up therapy if needed, first checking adherence, inhaler technique, and environmental control 5
The American Academy of Family Physicians recommends stepping down therapy if possible when asthma is well-controlled for at least three months 4
Using LABA monotherapy for asthma treatment increases the risk of asthma-related events, including deaths, according to the American College of Allergy, Asthma, and Immunology 2
Failing to step up therapy when a patient uses rescue SABA more than twice weekly indicates inadequate control, as stated by the American Academy of Family Physicians 6
Inadequate patient education on proper inhaler technique can significantly reduce medication effectiveness, as noted by the American College of Chest Physicians 1

The American Academy of Family Physicians recommends stepping up therapy when a patient uses a rescue short-acting beta-agonist more than twice weekly, indicating inadequate asthma control and progression to mild persistent disease, which requires daily controller medication 7

The American Academy of Family Physicians suggests that inhaled corticosteroid (ICS) therapy should be initiated when patients require a short-acting beta-agonist more than twice weekly, with the goal of reducing reliance on rescue medication through effective anti-inflammatory control 7

The American Thoracic Society recommends assessing medication adherence by directly questioning the patient about medication recall over the past several days before initiating controller therapy 8

The American Academy of Family Physicians recommends reassessing asthma control in 2-6 weeks after initiating ICS therapy, evaluating symptom frequency, nighttime awakenings, short-acting beta-agonist use, and interference with normal activities 7